Medicine compound for treating osteoporosis and osteoporosis fracture
An osteoporosis and composition technology, which is applied to the pharmaceutical composition of osteoporotic fractures, Huoxue Busui Shengguling Granules, in the field of treatment of osteoporosis, can solve the problem of high risk of osteoporotic fractures, high risk of surgical treatment of osteoporotic fractures, Side effects and complications
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0076] A medicine for treating osteoporosis and osteoporotic fractures, characterized in that it is prepared from the following raw materials in weight ratio: Drynaria: 30 grams, Dipsacus: 25 grams, Polygonum multiflorum: 15 grams, Tortoise shell: 22 grams, Epimedium: 20g, Wood Beetle: 9g, Natural Copper: 10g, Salvia: 20g, Safflower: 15g, Paeoniae Alba: 12g Clematis: 9g, Cnidium: 10g, chicken blood Vine: 12g, Angelica: 30g, Astragalus: 20g Yam: 22g, Poria: 12g, Rehmannia glutinosa: 20g, Antler gum: 15g, Dog spine: 15g Achyranthes bidentata: 12g, Eucommia: 10 Keel: 9 grams, Ligustrum lucidum: 15 grams, Psoraleae: 10 grams Atractylodes macrocephala: 12 grams, Melon seeds: 12 grams, Elderberry: 15 grams, Lycium barbarum: 15 grams, Qiannianjian: 10 grams sea octopus : 25g, Frankincense: 8g, Myrrh: 8g.
[0077] Preparation: According to the above formula, select high-quality pure natural Chinese medicinal materials, process them into medicinal powders according to conventional met...
Embodiment 2
[0080] Experimental Animals 32 BABC mice, half male and half female, clean grade, weighing 20-22 g, were provided by the Animal Center of Municipal People's Hospital. Divided into 4 groups at random, 8 in each group, namely blank control group 1, model control group 2, drug group 3 of the present invention, control drug group 4. Except for group 1 which was given normal saline, the rest of the groups were given dexamethasone 1 mg / kg, injected every three days, intramuscularly, and combined with retinoic acid, 70 mg / kg per day, for three weeks. Administration method During the modeling period, except that the blank control group and the model control group were given intragastric administration of equal volume of normal saline, the drug group of the present invention was administered by intragastric administration, and the dose was 0.5g / kg, three times a day. Linggubao capsule granules, the dose is 0.5g / kg, three times a day. Three weeks after administration, the number of tim...
Embodiment 3
[0084] clinical information
[0085] 227 patients with osteoporosis were selected from the cases in our hospital in recent years. The diseased sites were: 33 cases of cervical spine, 103 cases of lumbar spine, 51 cases of knee joint, 13 cases of ankle joint, and 27 cases of calcaneus. Randomly divided into a treatment group and a control group. The medical history, condition, age and gender of the selected cases in the treatment group and the control group were as similar as possible; the treatment group had 112 cases, aged 35-79 years; the control group had 115 cases, aged 38-80 years.
[0086] The treatment group took the medicine prepared in Example 1 of the present invention, 5 grams each time, 3 times a day, a course of treatment on 30 days, and took 2 courses of treatment continuously;
[0087] The control group received conventional drug Xianling Gubao Capsules (Guizhou Tongjitang Pharmaceutical Co., Ltd.). Take orally, 3 capsules each time, 2 times a day, divided into m...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com